Implantable Cardioverter Defibrillator (ICD)

This channel includes news and new technology innovations for implantable cardioverter defibrillators (ICD) used to treat tachycardia arrhythmias and heart failure. This includes cardiac resynchronization therapy defibrillators (CRT-D).

Medtronic Initiates Worldwide Pivotal Study of Extravascular Implantable Cardioverter Defibrillator
News | Implantable Cardioverter Defibrillator (ICD) | October 11, 2019

October 11, 2019 — Medtronic plc announced the start of a worldwide pivotal study evaluating its investigational...

Early ICD Use Prolongs Survival After Coronary Stenting
News | Implantable Cardioverter Defibrillator (ICD) | September 18, 2019

September 18, 2019 — Early use of an...

Cardiac Device Complications Vary Widely Among Hospitals
News | EP Lab | July 31, 2019

July 31, 2019 — The chances of patients experiencing complications after having a cardiac device implanted vary...

The Zoll Lifevest Wearable External Defibrillator Offers a Bridge Therapy and buys time for physicians to determine if an implantable defibrillator is needed.
News | Sudden Cardiac Arrest | July 02, 2019

For patients at risk for sudden cardiac arrest (SCA) who are being evaluated for a permanent implantable...

A physician explaining an implantable cardioverter defibrillator (ICD) to a patient. Image courtesy of Biotronik.

A physician explaining an implantable cardioverter defibrillator (ICD) to a patient. Image courtesy of Biotronik.

Feature | Implantable Cardioverter Defibrillator (ICD) | May 24, 2019 | Dave Fornell, Editor

This is a brief overview of updates on...

A new infection risk scoring system has been developed based on data from the large PADIT Trial.[1] The new scoring system was presented as a follow up to that study during a late-breaking session at Heart Rhythm 2019, the Heart Rhythm Society's 40th Annual Scientific Sessions.

Figure 1: The PADIT infection risk score ranging from 0 to 14 points classified patients into three risk groups, low (0-4), intermediate (5-6) and high (≥7). The risk groups had rates of hospitalization for infection of 0.51%, 1.42% and 3.41%, respectively 

News | EP Lab | May 15, 2019

May 15, 2019 — A new infection risk scoring system has been developed based on data from the large PADIT Trial.[1]...

Studies Find Race and Gender Disparities in Implantable Heart Devices
News | EP Lab | May 15, 2019

May 15, 2019 - Three new studies show that patients who are medically indicated for implantable heart devices,...

Heart Rhythm 2019 study shows travelers with common cardiac devices can pass through without restrictions or precautions. HRS 2019, #HRS #HRS19

A new study shows travelers with common cardiac devices can pass through airport body scanners without restrictions or precautions.

News | EP Lab | May 14, 2019

May 14, 2019 – Results from new research show that passengers with cardiac implantable electronic devices (CIEDs),...

Emblem Subcutaneous ICD Safe and Effective for Majority of Patients
News | Implantable Cardioverter Defibrillator (ICD) | May 13, 2019

May 13, 2019 — Boston Scientific announced acute results from the UNTOUCHED study evaluating safety and efficacy of...

News | EP Lab | May 13, 2019

May 13, 2019 – Results from a new survey are the first to report a large discrepancy in patient’s knowledge of their...

A first-in-human pilot study of Medtronic's investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system showed it can be implanted with no major complications, and can sense, pace and defibrillate the heart.

Medtronic's investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system.

News | May 13, 2019

May 13, 2019 – A first-in-human pilot study of Medtronic's investigational Extravascular Implantable Cardioverter...

Biotronik Launches Acticor DX and CRT-DX Devices in U.S.
News | Cardiac Resynchronization Therapy Devices (CRT) | April 29, 2019

April 29, 2019 — Biotronik announced the full commercial launch of the Acticor device family, including Acticor DX...

Biotronik Launches Acticor and Rivacor ICD and CRT-D Devices in Europe
News | Cardiac Resynchronization Therapy Devices (CRT) | April 18, 2019

April 18, 2019 – Biotronik announced the European market release of what it calls the world’s smallest...

Concerto CRT-D and Virtuoso ICD implantable cardiac devices are among several Medtronic electrophysiology devices included in a safety alert because of their lack of cybersecurity measures to avoid hacking, according to the FDA.

Concerto CRT-D and Virtuoso ICD implantable cardiac devices are among several Medtronic electrophysiology devices included in a safety alert because of their lack of cybersecurity measures to avoid hacking, according to the FDA.

Feature | EP Lab | March 22, 2019

March 22, 2019 — The U.S. Food and Drug Administration (FDA) issued a safety communication to alert healthcare...

Overlay Init